van der Meer J W, van de Kerkhof R, The G K, Boers G H
Universitair Medisch Centrum St Radboud, afd. Algemeen Interne Geneeskunde, Postbus 9101, 6500 HB Nijmegen.
Ned Tijdschr Geneeskd. 2003 Sep 6;147(36):1720-1.
In recent years, patients in the Netherlands confront their doctors with the diagnosis 'haemopyrollactamuria' (HPU), based on the presence of the haemopyrrollactam complex in their urine. The diagnosis is made by a commercial laboratory in the Netherlands (www.keac.nl). We have not been able to find peer-reviewed scientific literature on this metabolic disease. The haemopyrrollactam complex represents the so-called mauve spot, which was the subject of much controversy in schizophrenia research in the previous century. Reviewing all of the available data, we feel that HPU should be classified as a pseudo-disease.
近年来,荷兰的患者依据尿液中血吡咯内酰胺复合物的存在情况,向医生提出“血吡咯内酰胺尿症”(HPU)的诊断。该诊断由荷兰的一家商业实验室(www.keac.nl)做出。我们未能找到关于这种代谢性疾病的经过同行评审的科学文献。血吡咯内酰胺复合物代表所谓的紫红色斑点,在上个世纪的精神分裂症研究中,它是诸多争议的主题。综合所有现有数据,我们认为HPU应被归类为一种假性疾病。